Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy

Ten subjects received 600 to 1,200 mg of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor ritonavir per day. Following 2 weeks of therapy, plasma HIV RNA levels decreased by a mean of 1.57 (range, 0.89 to 1.96) log units. With continued therapy, HIV RNA levels began to rise in eigh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Eastman, P. Scott, Mittler, John, Kelso, Reed, Gee, Chris, Boyer, Eric, Kolberg, Janice, Urdea, Mickey, Leonard, John M., Norbeck, Daniel W., Mo, Hongmei, Markowitz, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1998
Assuntos:
Animal Viruses
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC110088/
https://ncbi.nlm.nih.gov/pubmed/9573287
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados